PMC:7755033 / 903-1321
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
30 | 164-168 | Gene | denotes | ACE2 | Gene:59272 |
32 | 202-207 | Gene | denotes | spike | Gene:43740568 |
38 | 158-163 | Species | denotes | human | Tax:9606 |
39 | 179-182 | Species | denotes | SAR | Tax:2698737 |
40 | 183-186 | Species | denotes | CoV | Tax:11118 |
41 | 191-201 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
42 | 246-256 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
47 | 109-111 | Species | denotes | WS | Tax:126910 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T12 | 56-267 | Sentence | denotes | Molecular docking analyses revealed that most of the WS phytoconstituents exhibited potent binding to human ACE2 receptor, SAR-CoV and SARS-CoV-2 spike glycoproteins as well as the two main SARS-CoV-2 proteases. |
T13 | 268-362 | Sentence | denotes | Most of the phytoconstituents were predicted to undergo Phase-I metabolism prior to excretion. |